GlassScriptPhysician profile
Nicole M Stout
NPI 1407072952
$7,164.38
in general payments reported to CMS, 2019-2025
51 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $541 · 2022: $1,218 · 2023: $1,908 · 2024: $1,825 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,141 · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,141.02 |
| Education | $263.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $549.95 | 2021-2023 | Imbruvica |
| Astrazeneca Pharmaceuticals LP | $536.56 | 2022-2025 | Imfinzi, Enhertu, Calquence |
| Abbvie INC. | $508.04 | 2022-2025 | |
| Daiichi Sankyo INC. | $505.03 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Novartis Pharmaceuticals Corporation | $438.44 | 2023-2025 | |
| Incyte Corporation | $419.44 | 2022-2025 | Jakafi, Monjuvi, Zynyz |
| Astellas Pharma US INC | $348.13 | 2021-2025 | Xtandi, Padcev, Xospata |
| Janssen Pharmaceuticals, INC | $311.70 | 2021-2024 | Xarelto |
| Celgene Corporation | $209.20 | 2023-2025 | Reblozyl, Opdualag, Pomalyst |
| Pfizer INC. | $196.01 | 2023-2024 | |
| Ipsen Biopharmaceuticals, INC | $195.10 | 2022-2025 | Onivyde, Somatuline Depot |
| Bayer Healthcare Pharmaceuticals INC. | $170.38 | 2021-2025 | |
| Pharmacosmos Therapeutics INC. | $169.21 | 2021-2024 | Monoferric |
| Shield Therapeutics INC | $169.13 | 2024-2025 | |
| Amgen INC. | $163.08 | 2021-2023 | Nplate, Vectibix, Xgeva |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $158.03 | 2021-2025 | Talvey, Tecvayli, Darzalex |
| Kite Pharma, INC. | $149.13 | 2021-2023 | Yescarta |
| Gilead Sciences, INC. | $145.60 | 2023-2024 | Trodelvy |
| Genzyme Corporation | $142.46 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $141.09 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Glaxosmithkline, LLC. | $110.09 | 2024-2025 | Ojjaara, Blenrep |
| Eisai INC. | $108.07 | 2021-2025 | |
| Seagen INC. | $105.24 | 2022-2023 | Tukysa, Adcetris, Padcev |
| E.R. Squibb & Sons, L.L.C. | $91.78 | 2021-2024 | Eliquis |
| Alexion Pharmaceuticals, INC. | $84.13 | 2021-2025 | Ultomiris |
| Mirati Therapeutics, INC. | $81.58 | 2023-2024 | Krazati |
| Aveo Pharmaceuticals, INC. | $77.93 | 2021-2025 | |
| Genmab U.S., INC. | $73.80 | 2023-2024 | Epkinly, Tivdak |
| Lilly USA, LLC | $72.15 | 2021-2023 | Retevmo, Jaypirca |
| Takeda Pharmaceuticals U.S.A., INC. | $64.71 | 2023 | Alunbrig, Ninlaro |
| Stemline Therapeutics INC. | $59.90 | 2023-2024 | Orserdu |
| Genentech USA, INC. | $55.41 | 2024-2025 | Venclexta, Perjeta, Phesgo |
| Jazz Pharmaceuticals INC. | $55.21 | 2024 | |
| Emd Serono, INC. | $46.73 | 2021-2022 | |
| Boston Scientific Corporation | $44.42 | 2023 | Watchman Access System |
| Spectrum Pharmaceuticals INC. | $44.06 | 2025 | Rolvedon |
| Pharmaessentia USA Corporation | $43.03 | 2023-2025 | Besremi |
| Taiho Oncology, INC. | $41.34 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $39.15 | 2021-2024 | Libtayo |
| Recordati_rare_diseases_inc. | $37.87 | 2024-2025 | Panhematin |
| Sandoz INC. | $21.59 | 2022 | |
| Apellis Pharmaceuticals, INC. | $21.46 | 2024 | Empaveli |
| Servier Pharmaceuticals LLC | $20.99 | 2024 | |
| Beigene USA, INC. | $19.97 | 2021 | |
| Blueprint Medicines Corporation | $19.56 | 2023 | Ayvakit |
| Puma Biotechnology, INC. | $19.04 | 2025 | |
| G1 Therapeutics, INC. | $18.64 | 2021 | |
| Clovis Oncology, INC. | $18.24 | 2021 | |
| Coherus Oncology, INC. | $17.40 | 2023 | |
| Rigel Pharmaceuticals, INC. | $14.97 | 2022 | |
| Bio Products Laboratory USA, INC. | $10.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Stout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.